Granules India Ltd.
BSE: 532482 | Sector: Health care |
NSE: GRANULES | ISIN Code: INE101D01020 |
BSE 10:06 | 20 Jan | 351.60 |
1.30 (0.37%) |
OPEN
350.00 |
HIGH
352.95 |
LOW
349.45 |
NSE 09:59 | 20 Jan | 351.60 |
1.25 (0.36%) |
OPEN
352.00 |
HIGH
353.00 |
LOW
349.55 |
OPEN | 350.00 |
PREVIOUS CLOSE | 350.30 |
VOLUME | 2090 |
52-Week high | 438.00 |
52-Week low | 114.50 |
P/E | 20.00 |
Mkt Cap.(Rs cr) | 8,709 |
Buy Price | 351.20 |
Buy Qty | 50.00 |
Sell Price | 351.65 |
Sell Qty | 107.00 |
About Granules India Ltd.
Granules India Limited is a large-scale vertically integrated company founded in March 18th 1991 manufacturing Active Pharmaceutical Ingredient (API) Pharmaceutical Formulation Intermediate (PFI) and Finished Dosage (FD). With a strong presence across all three vertical the company has created a leadership position in the off-patent drugs segment along with ensuring a strong presence in `first lin...> More
Granules India Ltd - Key Fundamentals
Parameter | Values | ||
Market Cap | (![]() |
8,709 | |
EPS - TTM | (![]() |
[*S] | 17.58 |
P/E Ratio | (X) | [*S] | 20.00 |
Face Value | (![]() |
1 | |
Latest Dividend | (%) | 25.00 | |
Latest Dividend Date | 28 Oct 2020 | ||
Dividend Yield | (%) | 0.29 | |
Book Value / Share | (![]() |
[*S] | 76.46 |
P/B Ratio | (![]() |
[*S] | 4.60 |
News
Announcement
-
Granules India Limited - Analysts/Institutional Investor Meet/Con. Call Updates
-
Board Meeting Intimation for Inter-Alia To Consider And Approve The Un-Audited Financial Results Fo
-
Announcement under Regulation 30 (LODR)-Press Release / Media Release
-
Statement Of Investor Complaints For The Quarter Ended December 2020
Granules India Ltd - Financial Results
Particulars (![]() |
Sep 2020 | Sep 2019 | % Chg |
Net Sales | 858.12 | 699.53 | 22.67 |
Other Income | 3.22 | 8.67 | -62.86 |
Total Income | 861.34 | 708.21 | 21.62 |
Total Expenses | 601.71 | 555.93 | 8.23 |
Operating Profit | 259.63 | 152.27 | 70.51 |
Net Profit | 163.63 | 95.79 | 70.82 |
Equity Capital | 24.76 | 25.42 | - |
Granules India Ltd - Peer Group
Company | Price(![]() |
Chg (%) | Mkt Cap (![]() |
Suven Pharma | 490.95 | 0.55 | 12499.59 |
P & G Health Ltd | 6865.50 | 0.87 | 11396.73 |
Astrazeneca Phar | 3977.30 | -1.72 | 9943.25 |
Granules India | 351.60 | 0.37 | 8709.13 |
ERIS Lifescience | 635.00 | 3.13 | 8623.30 |
Strides Pharma | 910.20 | 0.33 | 8159.03 |
J B Chem & Pharm | 1023.55 | 0.81 | 7912.04 |
Granules India Ltd - SHAREHOLDING PATTERN
|
|
Granules India Ltd - Research Reports
Granules India Ltd - RETURNS
Period | BSE | NSE | Sensex | NIFTY |
1 Week | -4.56% | -4.59% | 0.20% | 0.08% |
1 Month | -4.93% | -4.92% | 5.60% | 5.93% |
3 Month | -10.23% | -10.29% | 22.31% | 22.52% |
6 Month | 32.68% | 32.60% | 32.53% | 32.25% |
1 Year | 138.94% | 138.86% | 19.41% | 19.24% |
3 Year | 158.72% | 159.29% | 39.64% | 33.79% |
Granules India Ltd - STOCK STRENGTH
Today's Low/High | 349.45 | 352.95 | |
Week Low/High | 342.10 | 377.00 | |
Month Low/High | 322.00 | 380.00 | |
YEAR Low/High | 114.50 | 438.00 | |
All TIME Low/High | 1.58 | 438.00 |
Quick Links for Granules India:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices